Inspire Medical Systems Hits 52-Week Low at $51.59 Amid Market Struggles

Inspire Medical Systems, Inc., a small-cap player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 51.59 on March 23, 2026. This significant decline marks a stark contrast to the company's previous performance, with a one-year drop of 67.6%. In comparison, the S&P 500 has shown a positive performance of 16.12% over the same period. The company's market capitalization stands at USD 1,683 million, reflecting its position within the small-cap category. Inspire Medical Systems has a price-to-earnings (P/E) ratio of 11.00, indicating its valuation relative to earnings. The firm currently does not offer a dividend, as evidenced by a yield of 0.00%. Additionally, its debt-to-equity ratio is reported at -0.39, suggesting a unique financial structure, while the return on equity is a notable 19.13%. The price-to-book ratio is recorded at 2.15, providing insight into the company's valuation relative to its assets. The stock's previous 52-week high was USD 172.95, highlighting the extent of its recent decline.